Open clinical trials
The Breast Cancer Research Trust currently has the following clinical trials open to new patients:
The EXPERT clinical trial is a randomised phase 3 trial open to women aged 50 years or older, with Hormone Receptor (HR) positive, Human Epidermal Growth Factor Receptor 2 (HER2) negative, early stage breast cancer. EXPERT uses a genomic test of breast cancer tissue to select women who can safely avoid radiation therapy. The trial aims to improve personalised use of radiation therapy in early breast cancer patients, according to individual risk of local recurrence.
For more information contact: Jenni Scarlet, Research Nurse
Email: Jenni.Scarlet@waikatodhb.health.nz
Phone: 07 839 8726 ext 97916
A study evaluating a new online service for managing self-reported symptoms by women with advanced breast cancer
This is study evaluating a new service where patients complete weekly online surveys about common symptoms of advanced breast cancer (ABC) and side effects associated with ABC treatments. The survey responses are then sent to an ABC nurse who will use the responses to assist patients to better manage symptoms and side effects from home in between regular clinic visits. The survey responses will also help the patient's oncology team to decide if further tests or treatments are needed.
For more information contact: Jenni Scarlet, Research Nurse
Email: Jenni.Scarlet@waikatodhb.health.nz
Phone: 07 839 8726 ext 97916
This international clinical trial aims to enrol 4800 participants worldwide and will find out if using a specialised laboratory gene test (called a Prosigna assay) on breast cancer tissue can help Medical Oncologists and their patients make safe and accurate decisions about whether or not chemotherapy treatment is needed.
For more information contact:
Hina Pokaia, Research Nurse
Email: Hina.Pokaia@waikatodhb.health.nz
Phone: 07 839 8726 ext 97960
The aim of the CAMBRIA-2 international clinical trial is to prevent cancer from coming back for women and men diagnosed with early breast cancer. This is a hormone therapy clinical trial for people with oestrogen receptor positive and HER2 negative early breast cancer who have an intermediate to high, or high risk of recurrence.
For more information contact:
Jenni Scarlet, Research Nurse
Email: Jenni.Scarlet@waikatodhb.health.nz
Phone: 07 839 8726 ext 97916
This study is evaluating a new approach to imaging for women diagnosed with a large size breast cancer called invasive lobular breast cancer.
For more information contact:
Jenni Scarlet, Research Nurse
Email: Jenni.Scarlet@waikatodhb.health.nz
Phone: 07 839 8726 ext 97916
Breast specialist surgeons and radiologists are evaluating new non-wire non-radioactive pre-surgery localisation technologies. The aim of new technologies such as “Savi Scout” is to make breast surgery easier for women, while helping surgeons optimise their breast conserving surgery.
Proud members of the
Waikato Chamber of Commerce
P 07 839 8726 ext 97845
E admin@breastcancerresearch.org.nz
Breast Cancer Research Trust
Waikato Hospital
Private Bag 3200, Hamilton 3240
NEW ZEALAND